SIGNIFICANCE OF BONE DENSITOMETRY

Bone density scanning, also widely known as bone densitometry or dual-energy x-ray absorptiometry (DXA), is one of the most advanced forms of x-ray technology that is used widely to measure bone loss. Today, DXA has become one of the gold standards for measuring bone mineral density (BMD) accurately.

An x-ray exam helps the physicians to diagnose & treat medical conditions. It exposes an individual to a small dose of ionizing radiation to generate pictures of the various body insights. X-rays are the oldest & most commonly used form of medical imaging. In 2020, the total revenue share of the Global Bone Densitometer Market was around USD 300 Mn. It is predicted to reach a stunning landmark of around USD 449 Mn by 2030, along with a CAGR of 4.11 % throughout the forecasted time frame. 

North America was regarded as the fastest-growing market, with an overall valuation of more than US$ 150 Mn in 2020.

THE TOP 5 VENDORS THAT ARE OPERATING IN THE BONE DENSITOMETER MARKET ARE AS FOLLOWS:

CompuMed

CompuMed had recently developed a highly advanced system called OsteoGram, which is a bone density measurement software that is used for digital imaging & communications in medicine (DICOM) compliant systems. It works with the combination of standard or digital X-ray equipment and helps in detecting osteoporosis via therapy monitoring. CompuMed generated annual revenue of USD 338,436 in 2020, and it is anticipated to foster a robust CAGR throughout the prevised time frame. 

This software is highly compatible with DICOM-compatible digital X-ray devices. It accurately provides the diagnostic reports of a DXN scan by following the standard in-office X-ray procedure. The OsteoGram system determines the bone mineral mass and bone volume accurately from the radiographic scan data. The BMD is then calculated & compared with normal healthy bones, thus generating both Z -score and T-score for patient management.

DMS IMAGING

With a 360-degree specialization in high technology for medical diagnosis, DMS Imaging is regarded as one of the French leaders in the development, manufacture, and design of imaging systems for radiology, stereo radiography, bone densitometry, and podiatry. On January 20th, the French company published its financial results for Q4 2020. These showed that sales were lower this time during the quarter. Quarterly sales reached around €8.6Mn, as compared to €9.6Mn during Q4 2019, which is a decrease of almost 10% as a whole. On the other hand, the cumulative sales in 2020 reached a landmark of around €32.1Mn, as compared to €31Mn in 2019, which is an increase of nearly +4%.

DMS adequately manufactures & sells a variety of irradiation apparatus & tubes used in medical diagnostic, R&D, medical therapeutic, and other scientific applications. It also provides beta, X-ray, gamma, or other radiation equipment. Additionally, the company manufactures MRI equipment, CT scanners, PET scanners, ECGs, electromedical endoscopic equipment, medical ultrasound equipment, pacemakers, hearing aids, medical laser equipment, and food and milk irradiation equipment.

Over the years, DMS IMAGING has successfully established its presence in the global BDM market with its range of imaging systems for its digital and conventional radiology along with its wide range of bone densitometry applications worldwide.

GE Healthcare

GE Healthcare is one of the leading organizations in the world that entirely focuses on the expansion of its global presence in the Bone Densitometer Market with its wide range of bone densitometry solutions for providing 360-degree access to bone health assessment that adequately caters to the requirements of the patients. In 2020, the overall revenue for GE Healthcare totaled up to 18 billion U.S. dollars. 

On the other hand, the organization provides a dynamic range of tools that help the physicians diagnose & treat weakened bones accurately. The company offers a detailed portfolio of DXA solutions that address the specific requirements of the patients. These are specially designed in accordance with the latest generation technology & a variety of applications along with practice management tools.

Hologic

Hologic established its existence in the worldwide BDM market with its stunning range of BDMs under its Skeletal Health product bifurcations. The company generated annual revenue of around USD 3,776 million in 2020, and it is expected to continue its prosperity in the future with a decent CAGR.

The company specializes in delivering tools for diagnostics, medical imaging, and surgery to help people maintain stronger & healthier bones. It offers a 360-degree view of imaging solutions that can identify osteoporosis & fractures accurately. Hologic also introduced the first DXA system in the world in 1987.

Swissray

Based in Zurich, Switzerland, Swissray has established its presence successfully in the global Bone Densitometry Market with its profound range of BDMs through its key brand Norland.

The Norland XR-600 provides a clinical setting with highly advanced technologies for accurate assessments of bones. This scanner has a special feature with a pair of advanced detectors and a pair of advanced dynamic filtration technology, targeted to independently register high & low energy simultaneously. It delivers swift, precise, and accurate studies, regardless of operator-based analysis and body size.

Net profit/loss

USD2.2 Billion

 

(Excluding all the COVID-19 impacts)

 

USD 878 Million

 

(Including all the COVID-19 impacts)

 

 

Return on Equity (ROE)

7.3%

 

(Excluding all the COVID-19 impacts)

 

3.1%

 

(Including all the COVID-19 impacts)

 

2.5%

 

(2019)